AI & ML will now speed up the drug development process - InvoZone

IBM research contributed two platforms to this project. The RXN for chemistry uses natural language processing to automate synthetic chemistry and AI to make predictions about the success rate of the compounds used in the medicines. The company also uses an automated platform RoboRXN for molecule synthesis. The other company Arctoris used its automated platform Ulysses for the project which uses robots and digital data to conduct lab experiments in cell biology, molecular biology, and biophysics. And the experiments conducted by Ulysses generated 100 times more data in comparison to the industry-standard manual methods.